07.01.06
Nanotechnology-Based Policosanol
Valensa International has introduced Nanocosanol, a new advanced form of policosanol for the nutraceuticals market. This patent-pending nanotechnology-based product has a higher level of biofunctionality compared to existing policosanol supplements for promoting a heart-healthy lipid balance. Nanocosanol is available both in bulk packaging and in 500 mg softgels containing 15 mg policosanols nanodispersed in a proprietary mixture of cranberry seed and amaranth oils.
For further information: 352-357-2004.
Valensa International has introduced Nanocosanol, a new advanced form of policosanol for the nutraceuticals market. This patent-pending nanotechnology-based product has a higher level of biofunctionality compared to existing policosanol supplements for promoting a heart-healthy lipid balance. Nanocosanol is available both in bulk packaging and in 500 mg softgels containing 15 mg policosanols nanodispersed in a proprietary mixture of cranberry seed and amaranth oils.
For further information: 352-357-2004.